| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8210630 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 6 Pages |
Abstract
Definitive treatment with ADT-RT is associated with improved PCSM and ACM among patients with clinically node-positive prostate cancer and lower baseline PSA levels. Patients with clinically node-positive disease appear to be a heterogeneous cohort, with a subset who may achieve long-term survival with combined RT and ADT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Alex K. BS, Andrew K. MD, PhD, Rana R. MD, John P. MD, Loren K. MD, Arno J. MD, Christopher J. MD, Jason A. MD, PhD, James D. MD, Brent S. MD,